본문 바로가기
KERD
논문KCI 등재

Intestinal mucus components and secretion mechanisms: what we do and do not know

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Damage to the colon mucus barrier, the first line of defense against microorganisms, is an important determinant of intestinal diseases such as inflammatory bowel disease and colorectal cancer, and disorder in extraintestinal organs. The mucus layer has attracted the attention of the scientific community in recent years, and with the discovery of new mucosal components, it has become increasingly clear that the mucosal barrier is a complex system composed of many components. Moreover, certain components are jointly involved in regulating the structure and function of the mucus barrier. Therefore, a comprehensive and systematic understanding of the functional components of the mucus layer is clearly warranted. In this review, we summarize the various functional components of the mucus layer identified thus far and describe their unique roles in shaping mucosal structure and function. Furthermore, we detail the mechanisms underlying mucus secretion, including baseline and stimulated secretion. In our opinion, baseline secretion can be categorized into spontaneous Ca2+ oscillation-mediated slow and continuous secretion and stimulated secretion, which is mediated by massive Ca2+ influx induced by exogenous stimuli. This review extends the current understanding of the intestinal mucus barrier, with an emphasis on host defense strategies based on fortification of the mucus layer.

Abstract

Damage to the colon mucus barrier, the first line of defense against microorganisms, is an important determinant of intestinal diseases such as inflammatory bowel disease and colorectal cancer, and disorder in extraintestinal organs. The mucus layer has attracted the attention of the scientific community in recent years, and with the discovery of new mucosal components, it has become increasingly clear that the mucosal barrier is a complex system composed of many components. Moreover, certain components are jointly involved in regulating the structure and function of the mucus barrier. Therefore, a comprehensive and systematic understanding of the functional components of the mucus layer is clearly warranted. In this review, we summarize the various functional components of the mucus layer identified thus far and describe their unique roles in shaping mucosal structure and function. Furthermore, we detail the mechanisms underlying mucus secretion, including baseline and stimulated secretion. In our opinion, baseline secretion can be categorized into spontaneous Ca2+ oscillation-mediated slow and continuous secretion and stimulated secretion, which is mediated by massive Ca2+ influx induced by exogenous stimuli. This review extends the current understanding of the intestinal mucus barrier, with an emphasis on host defense strategies based on fortification of the mucus layer.

참고문헌 (117)

  1. Cardoso-Silva, D., "Intestinal barrier function in gluten-related disorders", Nutrients, 11, pp.2325~ (2019)
  2. Suzuki, T., "Regulation of the intestinal barrier by nutrients : the role of tight junctions", Anim. Sci. J, 91, pp.e13357~ (2020)
  3. Pelaseyed, T., "The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system", Immunol. Rev, 260, pp.8~20 (2014)
  4. Johansson, M. E., "Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis", Gut, 63, pp.281~291 (2014)
  5. Cone, R. A., "Barrier properties of mucus", Adv. Drug Deliv. Rev, 61, pp.75~85 (2009)
  6. Hansson, G. C., "The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria", Gut Microbes, 1, pp.51~54 (2010)
  7. Moncada, D., "Entamoeba histolytica cysteine proteinases disrupt the polymeric structure of colonic mucin and alter its protective function", Infect. Immun, 71, pp.838~844 (2003)
  8. Lidell, M. E., "Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel", Proc. Natl Acad. Sci. USA, 103, pp.9298~9303 (2006)
  9. Ordas, I., "Ulcerative colitis", Lancet, 380, pp.1606~1619 (2012)
  10. Ijssennagger, N., "Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?", Trends Mol. Med, 22, pp.190~199 (2016)
  11. Da Silva, S., "Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift : prevention by a probiotic treatment", Am. J. Physiol. Gastrointest. Liver Physiol, 307, pp.G420~G429 (2014)
  12. Corfield, A. P., "The interaction of the gut microbiota with the mucus barrier in health and disease in human", Microorganisms, 6, pp.78~ (2018)
  13. Nystrom, E. E. L., "Calcium-activated chloride channel regulator 1(CLCA1)forms non-covalent oligomers in colonic mucus and has mucin 2-processing properties", J. Biol. Chem, 294, pp.17075~17089 (2019)
  14. Lidell, M. E., "The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2in LS 174T cells", Biochem. J, 372, pp.335~345 (2003)
  15. Chen, E. Y., "A new role for bicarbonate in mucus formation", Am. J. Physiol. Lung Cell Mol. Physiol, 299, pp.L542~L549 (2010)
  16. Seidler, U. E., "Gastrointestinal HCO3-transport and epithelial protection in the gut : new techniques, transport pathways and regulatory pathways", Curr. Opin. Pharmacol, 13, pp.900~908 (2013)
  17. Recktenwald, C. V., "The reduction-insensitive bonds of the MUC2 mucin are isopeptide bonds", J. Biol. Chem, 291, pp.13580~13590 (2016)
  18. Nilsson, H. E., "Intestinal MUC2 mucin supramolecular topology by packing and release resting on D3 domain assembly", J. Mol. Biol, 426, pp.2567~2579 (2014)
  19. Bergstrom, K. S., "Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa", PLoS Pathog, 6, pp.e1000902~ (2010)
  20. Backhed, F., "Hostbacterial mutualism in the human intestine", Science, 307, pp.1915~1920 (2005)
  21. Shan, M., "Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals", Science, 342, pp.447~453 (2013)
  22. Thim, L., "A new family of growth factor-like Peptides ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide(pS2), pancreatic spasmolytic polypeptide(PSP), and frog skin peptides(spasmolysins)", FEBS Lett, 250, pp.85~90 (1989)
  23. Kjellev, S., "The trefoil factor family—small peptides with multiple functionalities", Cell Mol. Life Sci, 66, pp.1350~1369 (2009)
  24. Kouznetsova, I., "A gradient of TFF3(trefoil factor family 3)peptide synthesis within the normal human gastric mucosa", Cell Tissue Res, 316, pp.155~165 (2004)
  25. Meyer zum Buschenfelde, D., "Molecular mechanisms involved in TFF3 peptide-mediated modulation of the E-cadherin", catenin cell adhesion complex, 2004, pp.25, 873~883
  26. Meyer zum Buschenfelde, D., "TFF3-peptide increases transepithelial resistance in epithelial cells by modulating claudin-1 and-2expression", Peptides, 27, pp.3383~3390 (2006)
  27. Barrera, G. J., "Trefoil factor 3 isolated from human breast milk downregulates cytokines (IL8 and IL6) and promotes human beta defensin (hBD2 and hBD4) expression in intestinal epithelial cells HT-29", Bosn. J. Basic Med. Sci, 12, pp.256~264 (2012)
  28. Andoh, A., "Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells", J. Immunol, 167, pp.3887~3893 (2001)
  29. Yusufu, A., "TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process", Int. J. Oncol, 55, pp.789~804 (2019)
  30. Kobayashi, K., "Identification of a unique IgG Fc binding site in human intestinal epithelium", J. Immunol, 143, pp.2567~2574 (1989)
  31. Hoffmann, W., "Trefoil factor family(TFF)peptides and their different roles in the mucosal innate immune defense and more : an update", Curr. Med. Chem, 28, pp.7387~7399 (2021)
  32. Albert, T. K., "Human intestinal TFF3 forms disulfide-linked heteromers with the mucus-associated FCGBP protein and is released by hydrogen sulfide", J. Proteome Res, 9, pp.3108~3117 (2010)
  33. Wilhelm, B., "Identification and characterization of an IgG binding protein in the secretion of the rat coagulating gland", Biol. Chem, 383, pp.1959~1965 (2002)
  34. Zhang, Z., "Differential effects of EPA and DHA on DSS-induced colitis in mice and possible mechanisms involved", Food Funct, 12, pp.1803~1817 (2021)
  35. Yurtsever, Z., "Self-cleavage of human CLCA1 protein by a novel internal metalloprotease domain controls calcium-activated chloride channel activation", J. Biol. Chem, 287, pp.42138~42149 (2012)
  36. Melanie K. Bothe, "The Murine Goblet Cell Protein mCLCA3 Is a Zinc-Dependent Metalloprotease with Autoproteolytic Activity", Molecules and Cells, 32(6), pp.535~541 (2011), 한국분자세포생물학회
  37. Pauli, B. U., "Molecular characteristics and functional diversity of CLCA family members", Clin. Exp. Pharmacol. Physiol, 27, pp.901~905 (2000)
  38. Leverkoehne, I., "The murine mCLCA3(alias gob-5)protein is located in the mucin granule membranes of intestinal, respiratory, and uterine goblet cells", J. Histochem. Cytochem, 50, pp.829~838 (2002)
  39. Mundhenk, L., "Interspecies diversity of chloride channel regulators, calcium-activated 3 genes", PLoS One, 13, pp.e0191512~ (2018)
  40. Sala-Rabanal, M., "Secreted CLCA1modulates TMEM16A to activate Ca(2+)-dependent chloride currents in human cells", Elife, 4, pp.e05875~ (2015)
  41. Sala-Rabanal, M., "Modulation of TMEM16A channel activity by the von Willebrand factor type A(VWA)domain of the calcium-activated chloride channel regulator 1(CLCA1)", J. Biol. Chem, 292, pp.9164~9174 (2017)
  42. Jung, J., "Dynamic modulation of ANO1", TMEM16A HCO3(-)permeability by Ca2+, Proc. Natl Acad. Sci. USA, pp.2013, 110[DOI]
  43. i and its role in pancreatic bicarbonate secretion, "Gastroenterology", 2010, 620~631
  44. Mundhenk, L., "Both cleavage products of the mCLCA3 protein are secreted soluble proteins", J. Biol. Chem, 281, pp.30072~30080 (2006)
  45. Kuperman, D. A., "Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma", Nat. Med, 8, pp.885~889 (2002)
  46. Yu, H., "Interleukin-13 induces mucin 5AC production involving STAT6", SPDEF in human airway epithelial cells, 2010, pp.17, 83~92
  47. Brouillard, F., "Blue native", SDS-PAGE analysis reveals reduced expression of the mClCA3 protein in cystic fibrosis knock-out mice, 2005, pp.4, 1762~1775
  48. Young, F. D., "Amelioration of cystic fibrosis intestinal mucous disease in mice by restoration of mCLCA3", Gastroenterology, 133, pp.1928~1937 (2007)
  49. Dotti, I., "Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis", Gut, 66, pp.2069~2079 (2017)
  50. Erickson, N. A., "Role of goblet cell protein CLCA1 in murine DSS colitis", J. Inflamm, 13, pp.5~ (2016)
  51. Cronshagen, U., "cDNA cloning and characterization of a novel 16 kDa protein located in zymogen granules of rat pancreas and goblet cells of the gut", Eur. J. Cell Biol, 65, pp.366~377 (1994)
  52. Kleene, R., "The secretory lectin ZG16p mediates sorting of enzyme proteins to the zymogen granule membrane in pancreatic acinar cells", Eur. J. Cell Biol, 78, pp.79~90 (1999)
  53. Kanagawa, M., "Crystal structures of human secretory proteins ZG16p and ZG16b reveal a Jacalin-related beta-prism fold", Biochem. Biophys. Res. Commun, 404, pp.201~205 (2011)
  54. Tateno, H., "Human ZG16p recognizes pathogenic fungi through non-self polyvalent mannose in the digestive system", Glycobiology, 22, pp.210~220 (2012)
  55. Bergstrom, J. H., "Gram-positive bacteria are held at a distance in the colon mucus by the lectin-like protein ZG16", Proc. Natl Acad. Sci. USA, 113, pp.13833~13838 (2016)
  56. Meng, H., "Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer", BMC Cancer, 18, pp.433~ (2018)
  57. Meng, H., "ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer", Transl. Oncol, 14, pp.101003~ (2021)
  58. Holcomb, I. N., "FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family", EMBO J, 19, pp.4046~4055 (2000)
  59. Steppan, C. M., "A family of tissue-specific resistin-like molecules", Proc. Natl Acad. Sci. USA, 98, pp.502~506 (2001)
  60. He, W., "Bacterial colonization leads to the colonic secretion of RELMbeta", FIZZ2, a novel goblet cell-specific protein, 2003, pp.125, 1388~1397
  61. Bhatia, S., "Galacto-oligosaccharides may directly enhance intestinal barrier function through the modulation of goblet cells", Mol. Nutr. Food Res, 59, pp.566~573 (2015)
  62. Nair, M. G., "Goblet cell-derived resistin-like molecule beta augments CD4+T cell production of IFN-gamma and infection-induced intestinal inflammation", J. Immunol, 181, pp.4709~4715 (2008)
  63. McVay, L. D., "Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis", J. Clin. Investig, 116, pp.2914~2923 (2006)
  64. Propheter, D. C., "Resistin-like molecule beta is a bactericidal protein that promotes spatial segregation of the microbiota and the colonic epithelium", Proc. Natl Acad. Sci. USA, 114, pp.11027~11033 (2017)
  65. Watanabe, K., "Resistin-like molecule beta, a colonic epithelial protein, exhibits antimicrobial activity against Staphylococcus aureus including methicillin-resistant strains", Surg. Today, 50, pp.920~930 (2020)
  66. Bergstrom, K. S., "Goblet cell derived RELM-beta recruits CD4+ T cells during infectious colitis to promote protective intestinal epithelial cell proliferation", PLoS Pathog, 11, pp.e1005108~ (2015)
  67. Okumura, R., "Lypd8 promotes the segregation of flagellated microbiota and colonic epithelia", Nature, 532, pp.117~121 (2016)
  68. Okumura, R., "Lypd8 inhibits attachment of pathogenic bacteria to colonic epithelia", Mucosal. Immunol, 13, pp.75~85 (2020)
  69. Hsu, C. C., "Human LYPD8 protein inhibits motility of flagellated bacteria", Inflamm. Regen, 37, pp.23~ (2017)
  70. Xu, J., "LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL6 and TNFalpha", Oncol. Rep, 41, pp.2389~2395 (2019)
  71. Tomasi, T. B. Jr., "Characteristics of an immune system common to certain external secretions", J. Exp. Med, 121, pp.101~124 (1965)
  72. Strugnell, R. A., "The role of secretory antibodies in infection immunity", Nat. Rev. Microbiol, 8, pp.656~667 (2010)
  73. Schneeman, T. A., "Regulation of the polymeric Ig receptor by signaling through TLRs 3 and 4 : linking innate and adaptive immune responses", J. Immunol, 175, pp.376~384 (2005)
  74. Rogier, E. W., "Secretory IgA is concentrated in the outer layer of colonic mucus along with gut bacteria", Pathogens, 3, pp.390~403 (2014)
  75. Brandtzaeg, P., "Mucosal immunity : induction, dissemination, and effector functions", Scand. J. Immunol, 70, pp.505~515 (2009)
  76. Kaetzel, C. S., "Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualism", Immunol. Lett, 162, pp.10~21 (2014)
  77. Salerno-Goncalves, R., "Free and complexedsecretory immunoglobulin A triggers distinct intestinal epithelial cell responses", Clin. Exp. Immunol, 185, pp.338~347 (2016)
  78. Hultmark, D., "Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia", Eur. J. Biochem, 106, pp.7~16 (1980)
  79. Han, F., "Porcine beta-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis", J. Immunol, 194, pp.1882~1893 (2015)
  80. Yamaguchi, Y., "Antimicrobial peptide defensin : identification of novel isoforms and the characterization of their physiological roles and their significance in the pathogenesis of diseases", Proc. Jpn. Acad. Ser. B Phys. Biol. Sci, 88, pp.152~166 (2012)
  81. Midorikawa, K., "Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes", Infect. Immun, 71, pp.3730~3739 (2003)
  82. Hazlett, L., "Defensins in innate immunity", Cell Tissue Res, 343, pp.175~188 (2011)
  83. Cunliffe, R. N., "Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease", Gut, 48, pp.176~185 (2001)
  84. Ostaff, M. J., "Antimicrobial peptides and gut microbiota in homeostasis and pathology", EMBO Mol. Med, 5, pp.1465~1483 (2013)
  85. Zhang, G., "Avian antimicrobial host defense peptides: from biology to therapeutic applications", Pharmaceuticals, 7, pp.220~247 (2014)
  86. Selsted, M. E, "Mammalian defensins in the antimicrobial immune response", Nat. Immunol, 6, pp.551~557 (2005)
  87. Rohrl, J., "Human beta-defensin 2 and 3and their mouse orthologs induce chemotaxis through interaction with CCR2", J. Immunol, 184, pp.6688~6694 (2010)
  88. Loonen, L. M., "REG3gamma-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum", Mucosal. Immunol, 7, pp.939~947 (2014)
  89. Cash, H. L., "Symbiotic bacteria direct expression of an intestinal bactericidal lectin", Science, 313, pp.1126~1130 (2006)
  90. Ermund, A., "Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer’s patches", Am. J. Physiol. Gastrointest. Liver Physiol, 305, pp.G341~G347 (2013)
  91. Gustafsson, J. K., "Ex vivo measurements of mucus secretion by colon explants", Methods Mol. Biol, 842, pp.237~243 (2012)
  92. Zhu, Y., "Baseline goblet cell mucin secretion in the airways exceeds stimulated secretion over extended time periods, and is sensitive to shear stress and intracellular mucin stores", PLoS One, 10, pp.e0127267~ (2015)
  93. Cantero-Recasens, G., "KChIP3 coupled to Ca(2+)oscillations exerts a tonic brake on baseline mucin release in the colon", Elife, 7, pp.e39729~ (2018)
  94. Wollman, R., "Coordinated oscillations in cortical actin and Ca2+correlate with cycles of vesicle secretion", Nat. Cell Biol, 14, pp.1261~1269 (2012)
  95. Burger-van Paassen, N., "The regulation of intestinal mucin MUC2 expression by short-chain fatty acids : implications for epithelial protection", Biochem. J, 420, pp.211~219 (2009)
  96. Desai, M. S., "A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility", Cell, 167, pp.1339~1353 (2016)
  97. Huang, L., "Elevated miR-124-3p in the aging colon disrupts mucus barrier and increases susceptibility to colitis by targeting T-synthase", Aging Cell, 19, pp.e13252~ (2020)
  98. Jiang, Y., "Piezo1 regulates intestinal epithelial function by affecting the tight junction protein claudin-1 via the ROCK pathway", Life Sci, 275, pp.119254~ (2021)
  99. He, L., "Mechanical regulation of stem-cell differentiation by the stretch-activated Piezo channel", Nature, 555, pp.103~106 (2018)
  100. Bai, T., "Piezo2 : a candidate biomarker for visceral hypersensitivity in irritable bowel syndrome? J", Neurogastroenterol. Motil, 23, pp.453~463 (2017)
  101. Jiang, F., "The mechanosensitive Piezo1 channel mediates heart mechanochemo transduction", Nat. Commun, 12, pp.869~ (2021)
  102. Smirnova, M. G., "LPS up-regulates mucin and cytokine mRNA expression and stimulates mucin and cytokine secretion in goblet cells", Cell. Immunol, 221, pp.42~49 (2003)
  103. Tuvim, M. J., "Synaptotagmin 2 couples mucin granule exocytosis to Ca2+signaling from endoplasmic reticulum", J. Biol. Chem, 284, pp.9781~9787 (2009)
  104. Cantero-Recasens, G., "Sodium channel TRPM4 and sodium", calcium exchangers(NCX)cooperate in the control of Ca(2+)-induced mucin secretion from goblet cells, 2019, pp.294, 816~826
  105. Birchenough, G. M., "New developments in goblet cell mucus secretion and function", Mucosal. Immunol, 8, pp.712~719 (2015)
  106. Birchenough, G. M., "A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion", Science, 352, pp.1535~1542 (2016)
  107. Bauernfeind, F., "Cutting edge : reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome", J. Immunol, 187, pp.613~617 (2011)
  108. Wlodarska, M., "NLRP6 inflammasome orchestrates the colonic hostmicrobial interface by regulating goblet cell mucus secretion", Cell, 156, pp.1045~1059 (2014)
  109. Patel, K. K., "Autophagy proteins control goblet cell function by potentiating reactive oxygen species production", EMBO J, 32, pp.3130~3144 (2013)
  110. Shen, C., "Molecular mechanism for NLRP6 inflammasome assembly and activation", Proc. Natl Acad. Sci. USA, 116, pp.2052~2057 (2019)
  111. Leng, F., "NLRP6 self-assembles into a linear molecular platform following LPS binding and ATP stimulation", Sci. Rep, 10, pp.198~ (2020)
  112. Shigemura, H., "Up-regulation of MUC2 mucin expression by serum amyloid A3 protein in mouse colonic epithelial cells", J. Vet. Med. Sci, 76, pp.985~991 (2014)
  113. Reigstad, C. S., "Regulation of serum amyloid A3(SAA3)in mouse colonic epithelium and adipose tissue by the intestinal microbiota", PLoS One, 4, pp.e5842~ (2009)
  114. Iwashita, J., "mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells", Immunol. Cell Biol, 81, pp.275~282 (2003)
  115. Jones, L. C., "VAMP8 is a vesicle SNARE that regulates mucin secretion in airway goblet cells", J. Physiol, 590, pp.545~562 (2012)
  116. Ren, B., "SNAP23 is selectively expressed in airway secretory cells and mediates baseline and stimulated mucin secretion", Biosci. Rep, 35, pp.e00220~ (2015)
  117. Kim, K., "Munc18b is an essential gene in mice whose expression is limiting for secretion by airway epithelial and mast cells", Biochem. J, 446, pp.383~394 (2012)

관련 논문AI추천

이 간행물의 다른 논문 (225건)